Remove Dermatitis Remove Dermatology Remove Medical
article thumbnail

Important Updates on the Efficacy and Safety of JAK Inhibitors in Dermatology

The Dermatology Digest

Raj Chovatiya, MD, PhD, Founder and Director of the Center for Medical Dermatology and Immunology Research in Chicago, IL, reviews the latest efficacy and safety data on oral and topical Janus kinase (JAK) inhibitors used in dermatology. He spoke on this topic at the 2024 Revolutionizing Atopic Dermatitis (RAD) Conference.

Safety 74
article thumbnail

Oh, The Places Dermatology Will Go in 2024!

The Dermatology Digest

In 2023, dermatologists and their patients welcomed new drugs for acne, psoriasis, alopecia areata, and more, and 2024 promises to deliver real-world data on these medications along with even more therapeutic innovations across the spectrum of cutaneous diseases. We will, for sure, have new medications for chronic urticaria.”

article thumbnail

Eczema (Atopic Dermatitis) vs. Psoriasis: Understanding the Differences

First Derm

Different Triggers and Causes : Eczema flare-ups can be triggered by allergens and irritants, whereas psoriasis can be exacerbated by stress, infections, and certain medications. Contact dermatitis from metals, latex, chemicals. Medications (lithium, beta-blockers, NSAIDs). 2] Why is Eczema Considered a Chronic Condition?

Eczema 59
article thumbnail

The Cutaneous Connection: Pearls for Atopic Dermatitis in College-Aged Patients

Dermatology Times

In this episode, discover and learn how to address the unique challenges faced by college students diagnosed with atopic dermatitis—especially as they navigate new lifestyles and medication management.

article thumbnail

Atopic Dermatitis vs. Contact Dermatitis: What’s the Difference?

First Derm

Online Dermatologist Atopic Dermatitis vs. Contact Dermatitis: What’s the Difference? Atopic dermatitis (left) and contact dermatitis (right) display different symptoms. Contact Dermatitis : Triggered by external irritants or allergens, causing localized redness, blisters, and itching.

article thumbnail

New Ladder Helps Guide Choice of Non-steroidal Treatments in AD

The Dermatology Digest

A newly developed therapeutic ladder can help guide dermatologists and patients on the use of nonsteroidal treatment options for atopic dermatitis (AD). Ch’en, a medical student at the Albert Einstein College of Medicine in the Bronx, New York, and Peter A. The study appears in Dermatitis.

article thumbnail

The New Thinking About Seb Derm With Raj Chovatiya, MD, PhD

The Dermatology Digest

TDD Editorial Advisory Board Member Raj Chovatiya, MD, PhD, the Founder and Director of the Center for Medical Dermatology and Immunology Research in Chicago, updates viewers on the true role of Malassezia yeast in the pathophysiology of seborrheic dermatitis and explains how this new understanding is changing the way the condition is treated.